**Question:** Treatment of Torsades de pointes is intravenous

A. Amiodarone
B. Magnesium sulfate
C. Calcium channel blockers
D. Sodium bicarbonate

**Core Concept:** Torsades de pointes is a life-threatening ventricular arrhythmia, characterized by polymorphic ventricular tachycardia, often associated with QT interval prolongation. This arrhythmia can be caused by various factors, such as certain medications, electrolyte imbalances, or genetic predispositions.

**Why the Correct Answer is Right:** Amiodarone is a class III antiarrhythmic drug that can effectively suppress Torsades de pointes by correcting the abnormal QT interval. It works by blocking potassium channels, decreasing the outward potassium current, and lengthening the action potential duration, which helps to stabilize the arrhythmia.

**Why Each Wrong Option is Incorrect:**

- **B. Magnesium sulfate:** Magnesium sulfate is primarily used to treat eclampsia and convulsions during pregnancy, not specifically for Torsades de pointes. While it can have a small effect on QT interval prolongation, it is not a first-line treatment for this particular arrhythmia.
- **C. Calcium channel blockers:** Calcium channel blockers are primarily used for hypertension and angina, not for treating Torsades de pointes. They may worsen the arrhythmia due to their effect on prolonging the QT interval.
- **D. Sodium bicarbonate:** Sodium bicarbonate is commonly used to treat hypokalemia (low potassium levels) and acidosis but is not a primary treatment for Torsades de pointes. It may not address the underlying cause of the arrhythmia and could potentially worsen it.

**Clinical Pearl:** In clinical practice, it is essential to identify the underlying cause of Torsades de pointes (e.g., electrolyte imbalances, medications) and address these issues before considering specific antiarrhythmic treatment. Consulting a cardiologist is often necessary in managing this life-threatening arrhythmia.